Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
Launched by YUN LIU,PHD · Feb 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing a new system that helps diagnose and treat certain brain disorders in children, such as Cerebral Palsy, Mental Retardation, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder (ADHD), and Autism Spectrum Disorders. The researchers are using a combination of advanced technology and knowledge from both Chinese and Western medicine to create tools for prevention, decision-making, and follow-up support for affected children and their families.
If your child is between the ages of 730 days (about 2 years) and 6574 days (about 18 years) and has been diagnosed with one of the conditions mentioned, they may be eligible to participate in this trial. However, children with certain other serious mental illnesses or specific health issues may not be able to join. Participants can expect to receive support and guidance throughout the process, helping them understand their child's condition better and find the best ways to manage it. The trial is currently looking for volunteers, and everyone, regardless of gender, is welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited;
- Exclusion Criteria:
- • 1. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors;
- • 2. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease);
About Yun Liu,Phd
Dr. Yun Liu is a distinguished clinical trial sponsor with a robust background in biomedical research and drug development. With a PhD in a relevant scientific discipline, Dr. Liu has demonstrated expertise in designing and implementing innovative clinical trials aimed at advancing therapeutic solutions. Committed to fostering collaboration and adhering to regulatory standards, Dr. Liu leads initiatives that prioritize patient safety and scientific rigor, ensuring the integrity and success of each trial. Through a strategic approach to research and a dedication to improving healthcare outcomes, Dr. Liu is a pivotal contributor to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported